Exponent (EXPO) came out with quarterly earnings of $0.50 per share, beating the Zacks Consensus Estimate of $0.48 per share. This compares to earnings of $0.48 per share a year ago. These figures are ...

Scientific consulting firm Exponent (NASDAQ:EXPO) reported Q2 CY2025 results exceeding the market’s revenue expectations , with sales up 7.2% year on year to $142 million. On the other hand, next ...

Exponent’s revenue has grown at a CAGR of 6% while EBITDA has at 8%. This has been driven by its fantastic business model and industry tailwinds. Exponent provides highly complex consulting services ...

Q2 2025 Management View CEO Catherine Ford Corrigan reported that "revenues in the second quarter were flat but exceeded our expectations, reflecting our team's disciplined execution and resilience in ...